leucovorin calcium / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 424 Diseases   809 Trials   809 Trials   14393 News 


«12...198199200201202203204205206207208...235236»
  • ||||||||||  Avastin (bevacizumab) / Roche, Erbitux (cetuximab) / Eli Lilly, LEAC-102 / Taiwan Bio
    New P1/2 trial, Combination therapy, Metastases:  LEAC-102 for Advanced Colorectal Cancer (clinicaltrials.gov) -  Jul 11, 2016   
    P1/2,  N=30, Not yet recruiting, 
  • ||||||||||  buparlisib (AN2025) / Adlai Nortye
    Trial completion, Enrollment change, Trial primary completion date, Metastases:  BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer (clinicaltrials.gov) -  Jul 5, 2016   
    P1,  N=17, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Mar 2016 Recruiting --> Completed | N=60 --> 17 | Trial primary completion date: Jul 2016 --> May 2015
  • ||||||||||  HyperAcute Pancreas (algenpantucel-L) / Lumos Pharma
    Enrollment change, Trial termination:  Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer (clinicaltrials.gov) -  Jul 1, 2016   
    P2,  N=10, Terminated, 
    Active, not recruiting --> Completed N=48 --> 10 | Active, not recruiting --> Terminated
  • ||||||||||  BI 695502 (bevacizumab biosimilar) / Boehringer Ingelheim
    Enrollment open, Metastases:  INVICTAN (clinicaltrials.gov) -  Jun 28, 2016   
    P3,  N=120, Recruiting, 
    N=168 --> 509 Not yet recruiting --> Recruiting
  • ||||||||||  leucovorin calcium / Generic mfg.
    New P3 trial:  Folinic Acid: Supplementation and Therapy (clinicaltrials.gov) -  Jun 22, 2016   
    P3,  N=69, Completed, 
  • ||||||||||  leucovorin calcium / Generic mfg.
    Enrollment open, Phase classification:  EFFET: Folinic Acid in Children With Autism Spectrum Disorders (clinicaltrials.gov) -  Jun 16, 2016   
    P2,  N=40, Recruiting, 
    Trial primary completion date: Mar 2016 --> Jul 2016 Not yet recruiting --> Recruiting | Phase classification: P4 --> P2
  • ||||||||||  5-fluorouracil / Generic mfg., metformin / Generic mfg., leucovorin calcium / Generic mfg.
    Trial primary completion date, Metastases:  Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer (clinicaltrials.gov) -  Jun 10, 2016   
    P2,  N=43, Recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Jun 2016 --> Dec 2016
  • ||||||||||  futuximab/modotuximab (S95026) / Servier
    Phase classification, Combination therapy, Metastases:  Sym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer Patients (clinicaltrials.gov) -  Jun 5, 2016   
    P1b/2a,  N=50, Recruiting, 
    Trial primary completion date: May 2016 --> May 2017 Phase classification: P1/2 --> P1b/2a
  • ||||||||||  HyperAcute Pancreas (algenpantucel-L) / Lumos Pharma
    Enrollment closed:  Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer (clinicaltrials.gov) -  Jun 1, 2016   
    P2,  N=48, Active, not recruiting, 
    Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting